MIRA
INFORM REPORT
|
Report Date : |
17.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
EUROPHARM LABORATOIRES COMPANY LIMITED |
|
|
|
|
Registered Office : |
Tai Po Industrial Estate 12-14 Dai Wang St, New Territories, |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
28.02.1986 |
|
|
|
|
Com. Reg. No.: |
0165931 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Trading Wide Range of Pharmaceutical and Healthcare Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
|
Maximum Credit Limit : |
USD 100,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
COMPANY NAME &
ADDRESS
EUROPHARM LABORATOIRES CO LTD
TAI PO INDUSTRIAL ESTATE 12-14 DAI WANG ST, NEW TERRITORIES, HONG KONG.
TEL: 852-26062788
FAX: 852-26070980
EXECUTIVE SUMMARY
INCORPORATION DATE :
FEBRUARY 28, 1986
REGISTRATION NO. :
0165931
LEGAL FORM :
PRIVATE
CHIEF EXECUTIVE :
MR. WILLIAM HON-KWONG LEE (GENERAL MANAGER)
STAFF STRENGTH :
10
CAPITAL :
US$ 6,402,049
BUSINESS LINE :
TRADER
TURNOVER :
N/A (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
AVERAGE
RECOMM. CREDIT RANGE :
UP TO USD 100,000
MARKET CONDITION :
AVERAGE
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
HKD 7.79691 = US$1
*OTHER LICENSE*
================
License Number :
10197423-000
Issuing Authority :
Business Registration Office - Inland Revenue Dept
*Company History*
===============
June 2000 - Finished the new premises in Tai Po Industrial
Estate.
*Capital Details*
=============
Share value : HKD 1.00/-each
Authorized capital : HKD
50,000,000.00
Paid-up capital : HKD 18,000,009.00
*Office & Facilities*
================
Size : 4,000 sq meter
Type of building : 4-storey
building
Other tel no. : 26622433 (Customer service)
Previous address : Unit 24, 16Fl Goldfield Industrial
Centre 1 Sui Wo Rd, Fotan, New Territories
*Charges*
========
Total amount outstanding as of date of this return on all mortgages and
charges which are required to be registered with the Register of Companies is
HKD 39,000,000.00.
*Approved Signatures*
==================
Only Mr. Derek Kwong-yip Sum can sign on behalf of the company with seal
affixed.
www.europharm.com.hk The
design is professional and the content is well organized. At present it is in
both Chinese and English versions.
E-mail: info@europharm.com.hk
For the past two years there is no record of litigation.
*Major Shareholders*
================
Total number of shareholders: 5
Total number of shares: 18,000,009
Shareholders Country Number Amount (HKD) %
JACOBSON MEDICAL Virgin
Islands (British) 13,500,009.00 13,500,009.00 75.00
OVERSEAS (HOLDINGS) LTD
Mr. Wai-king Fung Hong Kong 2,790,000.00 2,790,000.00 15.50
Mr. Chi-sheung Tsui Hong Kong 630,000.00 630,000.00 3.50
Mr. Siu-lee Chik Hong Kong 540,000.00 540,000.00 3.00
Mr. William Hon-kwong Lee Hong Kong 540,000.00 540,000.00 3.00
*Directors' Details*
===============
Shareholders' Details
----------------------------
Chi-sheung Tsui
Address : Rm 2333 Tai Lok House Tai Yuen Estate, Tai Po, New Territories
Hong Kong
Siu-lee Chik
Address : Rm 2026 Hok Sam House Lung Hong Estate, Shatin, New
Territories Hong Kong
*Corporate Secretary*
=================
SHUM LAW CORPORATE SERVICES LTD
C. R. number : 209105
Address : Suite 1101 Bank Centre 630-636 Nathan Rd,
Mongkok, Kowloon
Management: Mr. William Hon-kwong Lee, General Manager
Name Nationality
Job Description Dept. / Division
Mr. William Hon-kwong Lee Hong
Kong General Manager -
*Main Products & Services*
======================
Specializes in trading wide range of pharmaceutical and healthcare
products.
Products: Analgesics
Antacids
Anti bacterial
Antibiotics
Antipyretics
*Payment Terms*
==============
Sales
-------
Local : Cash or credit
Export : Letter of Credit (L/C)
Telegraphic
Transfer (T/T)
Purchases
--------------
Local : Cash or credit
Import : Letter of Credit (L/C)
Telegraphic
Transfer (T/T)
*Associations*
============
Member of:
- Federation of Hong Kong Industries
*Local Distribution Network*
=======================
Part of the annual turnover is attributed to local sales.
*Export Markets*
==============
Part of the annual turnover is attributed to export.
*Subsidiaries, Joint-ventures & Affiliates*
===============================
Maintains a factory in China.
PAYMENT RATING : 3 OBTAINED SCORES : 60
|
Rating Key |
Implication |
Implications |
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the payment pattern of SC based
upon our Payment Database, comments from suppliers of SC, information from
banks (if available), as well as industrial sources.
Dealings on open terms may be possible for MODERATE amounts depending on individual judgement experience.
As a private limited company there is no legal requirement according to
local corporate law for public disclosure of detailed financial.
SC is considered small-sized in its line with a development history of
22 years. Taking into consideration of SC’s general performance, a credit line
up to USD 100,000 appears to be within SC’s capacities.
Attached: trade references
SIC PRODUCT
CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2833
Medicinals and botanicals
Trading 2834
Pharmaceutical preparations
Trading 5047
Medical/Dental Equip/Supplies
Trading 5122
Drugs/Druggists' Sundries
HARMONIZED
PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2933 Heterocyclic comp, nit
hetero-atom; nucleic acids
Trading 2933903100
Analgesics, antipyretics and
non-hormonal anti-inflammatory agents
Trading 2941
Antibiotics
Trading 3000
Pharmaceutical products
Trading 3004
Medicaments, mixed or not,
in dosage etc form
Trading 3004400050
Dermatological agents and local
anesthetics
Trading 3004906055
Antacids
Trading 3004906090 Medicaments not elsewhere specified or
included
Trading 3006
Pharmaceutical goods
(specified sterile prod etc.)
Trading 3304990010
Cosmetic creams, lotions, oils and
balms
DETAILED PRODUCT CLASSIFICATION &
ACTIVITY
Activity Product/Service
Description
Trader Cream
Trader Ointment
Trader Eye drops
Trader Pharmaceutical products
Trader Analgesics
Trader Antipyretics
Trader Antacids
Trader Antiulcerant
Trader Antibiotics
Trader Anti bacterial
INTERNATIONAL TRADE: ACTIVITY & MARKETS
Country / Region Trading Type
Asia / Pacific Exporting,Importing
Europe Exporting
China Importing
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.78 |
|
UK Pound |
1 |
Rs.85.51 |
|
Euro |
1 |
Rs.67.90 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)